This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Design and docking of novel series of hybrid xanthones as anti-cancer agent to target human DNA topoisomerase 2-alpha, Bangladesh Journal of Pharmacology, May 2014, Bangladesh Journals Online (BanglaJOL),
DOI: 10.3329/bjp.v9i2.18180.
You can read the full text:
The following have contributed to this page
